Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism
- 29 June 2000
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (26), 1953-1958
- https://doi.org/10.1056/nejm200006293422604
Abstract
The length of time after an episode of venous thromboembolism during which the risk of newly diagnosed cancer is increased is not known, and whether vitamin K antagonists have an antineoplastic effect is controversial.Keywords
This publication has 10 references indexed in Scilit:
- Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/PhosphataseThrombosis and Haemostasis, 1999
- The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary EmbolismNew England Journal of Medicine, 1998
- Venous thromboembolism and cancerThe Lancet, 1998
- Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study.Journal of Clinical Oncology, 1997
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- Cancer Incidence and Mortality in Patients with Heart DiseaseAmerican Journal of Clinical Oncology, 1995
- Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic CancerNew England Journal of Medicine, 1992
- Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75Published by American Medical Association (AMA) ,1981
- Cancer morbidity and mortality in previously anticoagulated patientsThrombosis Research, 1980
- CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPYThe Lancet, 1964